Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Psycholinguistics | 1 | 2018 | 17 | 0.77 | Why? |
| Actinomycosis | 1 | 2018 | 17 | 0.76 | Why? |
| Spinal Cord Compression | 1 | 2018 | 35 | 0.75 | Why? |
| Pattern Recognition, Visual | 1 | 2018 | 32 | 0.75 | Why? |
| Paraplegia | 1 | 2018 | 38 | 0.74 | Why? |
| Wound Infection | 1 | 2018 | 66 | 0.70 | Why? |
| Daptomycin | 1 | 2018 | 64 | 0.70 | Why? |
| Thoracic Diseases | 1 | 2018 | 118 | 0.68 | Why? |
| Plague | 2 | 2018 | 155 | 0.67 | Why? |
| Unnecessary Procedures | 1 | 2019 | 175 | 0.67 | Why? |
| Brain Mapping | 1 | 2018 | 228 | 0.67 | Why? |
| Speech Perception | 1 | 2018 | 132 | 0.64 | Why? |
| Memory | 1 | 2017 | 137 | 0.62 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.61 | Why? |
| Cerebral Cortex | 1 | 2018 | 276 | 0.60 | Why? |
| Inappropriate Prescribing | 1 | 2019 | 284 | 0.60 | Why? |
| Hydroxychloroquine | 9 | 2021 | 12447 | 0.54 | Why? |
| Pericarditis | 1 | 2019 | 417 | 0.51 | Why? |
| Hospital Administration | 1 | 2020 | 650 | 0.50 | Why? |
| Internal Medicine | 1 | 2019 | 557 | 0.50 | Why? |
| Clinical Trials as Topic | 4 | 2020 | 7330 | 0.50 | Why? |
| Blood Chemical Analysis | 1 | 2017 | 541 | 0.49 | Why? |
| Endocarditis | 1 | 2018 | 368 | 0.49 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2020 | 1138 | 0.44 | Why? |
| Practice Patterns, Physicians' | 2 | 2019 | 4927 | 0.41 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.39 | Why? |
| Antiviral Agents | 9 | 2021 | 41703 | 0.36 | Why? |
| Interferon beta-1a | 2 | 2021 | 316 | 0.35 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.32 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.32 | Why? |
| France | 8 | 2021 | 12074 | 0.28 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.27 | Why? |
| Registries | 2 | 2020 | 12327 | 0.26 | Why? |
| Azithromycin | 4 | 2020 | 3943 | 0.24 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.23 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.23 | Why? |
| Chloroquine | 3 | 2020 | 3152 | 0.22 | Why? |
| Immunosuppressive Agents | 1 | 2019 | 6331 | 0.21 | Why? |
| Yersinia pestis | 2 | 2018 | 58 | 0.21 | Why? |
| Aggregatibacter actinomycetemcomitans | 1 | 2018 | 8 | 0.19 | Why? |
| Pasteurellaceae Infections | 1 | 2018 | 9 | 0.19 | Why? |
| Propionibacterium acnes | 1 | 2018 | 19 | 0.19 | Why? |
| Time | 1 | 2021 | 631 | 0.18 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.18 | Why? |
| Therapies, Investigational | 1 | 2020 | 235 | 0.18 | Why? |
| Thoracic Vertebrae | 1 | 2018 | 97 | 0.17 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.17 | Why? |
| Outpatients | 2 | 2020 | 3417 | 0.17 | Why? |
| History, 16th Century | 1 | 2017 | 104 | 0.17 | Why? |
| Guinea | 1 | 2017 | 228 | 0.16 | Why? |
| Paintings | 1 | 2017 | 35 | 0.16 | Why? |
| History, 17th Century | 1 | 2017 | 172 | 0.16 | Why? |
| History, 18th Century | 1 | 2017 | 192 | 0.16 | Why? |
| Still's Disease, Adult-Onset | 1 | 2017 | 100 | 0.15 | Why? |
| Medicine in the Arts | 1 | 2017 | 58 | 0.15 | Why? |
| Drug Hypersensitivity Syndrome | 1 | 2017 | 74 | 0.15 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2020 | 422 | 0.15 | Why? |
| History, 19th Century | 1 | 2017 | 384 | 0.14 | Why? |
| Drug Resistance, Viral | 1 | 2021 | 1083 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.14 | Why? |
| Humans | 32 | 2021 | 930598 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.14 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Pneumonia, Viral | 8 | 2021 | 243684 | 0.12 | Why? |
| Coronavirus Infections | 9 | 2021 | 253789 | 0.12 | Why? |
| Nervous System Diseases | 2 | 2020 | 4092 | 0.11 | Why? |
| Fasting | 1 | 2017 | 555 | 0.11 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.11 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.11 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.11 | Why? |
| Air Microbiology | 1 | 2020 | 1322 | 0.11 | Why? |
| Islam | 1 | 2017 | 545 | 0.11 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.11 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.10 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.10 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Guideline Adherence | 1 | 2021 | 2309 | 0.09 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Male | 10 | 2021 | 367725 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.07 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.07 | Why? |
| Adult | 6 | 2021 | 244371 | 0.06 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.06 | Why? |
| Health Behavior | 1 | 2021 | 4449 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.06 | Why? |
| Mali | 1 | 2021 | 181 | 0.06 | Why? |
| Attitude of Health Personnel | 1 | 2019 | 4741 | 0.05 | Why? |
| Luxembourg | 1 | 2020 | 125 | 0.05 | Why? |
| Drug Tolerance | 1 | 2020 | 100 | 0.05 | Why? |
| Surveys and Questionnaires | 2 | 2019 | 43792 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Myelitis | 1 | 2020 | 122 | 0.05 | Why? |
| Siphonaptera | 1 | 2018 | 21 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Masks | 1 | 2021 | 8528 | 0.04 | Why? |
| Imatinib Mesylate | 1 | 2020 | 327 | 0.04 | Why? |
| Aged | 5 | 2021 | 215776 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Publications | 1 | 2021 | 463 | 0.04 | Why? |
| Particle Size | 1 | 2020 | 1052 | 0.04 | Why? |
| Bias | 1 | 2020 | 1109 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Risk Reduction Behavior | 1 | 2020 | 946 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Research Personnel | 1 | 2021 | 1037 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.02 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.02 | Why? |
| Amides | 1 | 2020 | 1864 | 0.02 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Canada | 1 | 2021 | 6018 | 0.02 | Why? |
| Japan | 1 | 2021 | 6653 | 0.02 | Why? |
| Guillain-Barre Syndrome | 1 | 2020 | 1495 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Brain | 1 | 2020 | 5133 | 0.02 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Peiffer-Smadja's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(209)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_